17 results
PRE 14A
ELVN
Enliven Therapeutics Inc
15 Apr 24
Preliminary proxy
4:05pm
-employee director, as defined pursuant to Rule 16b-3 promulgated under the Exchange Act. The purpose of our compensation committee is to oversee our
DEF 14A
ltcprp
18 May 21
Definitive proxy
4:06pm
10-K
55o2vzvoomip7k5cvm3
5 Mar 21
Annual report
7:26am
10-Q
3wbup9k03h9025q9llg
7 May 20
Quarterly report
8:12am
424B4
2309v1 kww1
12 Mar 20
Prospectus supplement with pricing info
4:03pm
S-1/A
u0g5 nnki1ehy5
3 Mar 20
IPO registration (amended)
6:13am
S-1
yvoi9uy9cn7
14 Feb 20
IPO registration
5:05pm
DRS/A
6th8ebw14mv6o0b
8 Oct 19
Draft registration statement (amended)
12:00am
DRS
6gb 1bpnszx
15 Aug 19
Draft registration statement
12:00am
- Prev
- 1
- Next